Researchers at Cincinnati Children’s Hospital Medical Center in the US have designed and tested a new computerised solution which uses artificial intelligence (AI) to effectively identify eligible participants from electronic health records (EHRs).
The study, conducted in the Emergency Department, demonstrated that automated patient screening eases enrolment.
Go deeper with GlobalData
The new technology allows busy clinical staff to focus their time on evaluating the high priority candidates eligible for trials.
It is reported that the technology would improve patient recruitment for clinical trials.
The research revealed that Automated Clinical Trial Eligibility Screener (ACTES) system reduced patient screening time by 34% and improved patient enrolment by 11.1%.
Additionally, ACTES improved the number of patients screened by 14.7% and those approached by 11.1%.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe natural language processing of the system enables computers to understand human language as the system analyses large amounts of linguistic data.
This makes it possible for computer programmes to interpret and generate knowledge independently.
The machine learning component of the system also allows it to study historical enrolments to improve future recommendations, the researchers said.
Cincinnati Children’s Hospital Medical Center Division of Biomedical Informatics faculty member Yizhao Ni said: “Because of the large volume of data documented in EHRs, the recruiting processes used now to find relevant information are very labor intensive within the short time frame needed.
“By leveraging natural language processing and machine learning technologies, ACTES was able to quickly analyse different types of data and automatically determine patients’ suitability for clinical trials.”
The study was supported by funding from National Institutes of Health (1R01LM012230, 1U01HG008666, 5U18DP006134), Agency for Healthcare Research and Quality (1R21HS024983), and from Cincinnati Children’s Hospital Medical Centre.
